206 related articles for article (PubMed ID: 23164050)
1. Treatment of postoperative cystoid macular oedema with dexamethasone intravitreal implant in a vitrectomized eye -- a case report.
Merkoudis N; Granstam E
Acta Ophthalmol; 2013 May; 91(3):e238-9. PubMed ID: 23164050
[No Abstract] [Full Text] [Related]
2. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
[No Abstract] [Full Text] [Related]
3. Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker.
Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
Retina; 2014 Aug; 34(8):1612-6. PubMed ID: 24752008
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
[TBL] [Abstract][Full Text] [Related]
5. Cystoid macular edema associated with juvenile idiopathic arthritis resolved by a dexamethasone intravitreal implant.
Totan Y; Güler E; Guragaç FB; Dervisogullari MS; Tenlik A; Hepsen IF
J Pediatr Ophthalmol Strabismus; 2014 May; 51 Online():e25-8. PubMed ID: 24811080
[TBL] [Abstract][Full Text] [Related]
6. The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.
Ahn SJ; Kim KE; Woo SJ; Park KH
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):160-4. PubMed ID: 24506098
[TBL] [Abstract][Full Text] [Related]
7. Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting.
Parodi MB; Iacono P; Cascavilla M; Zucchiatti I; Bandello F
Acta Ophthalmol; 2012 Jun; 90(4):e322-3. PubMed ID: 21939501
[No Abstract] [Full Text] [Related]
8. Macular hole closure following intravitreal triamcinolone injection in a previously vitrectomized diabetic eye.
Kwon YH; Chung H; Kim JG; Yoon YH
Acta Ophthalmol; 2009 Feb; 87(1):111-2. PubMed ID: 18507730
[No Abstract] [Full Text] [Related]
9. Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling.
Bonfiglio V; Fallico MR; Russo A; De Grande V; Longo A; Uva MG; Reibaldi M; Avitabile T
Eur J Ophthalmol; 2015 Jul; 25(5):e98-e100. PubMed ID: 25790811
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.
Lei S; Lam WC
Can J Ophthalmol; 2015 Jun; 50(3):236-41. PubMed ID: 26040225
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of the dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to central retinal vein occlusion.
Shaikh AH; Petersen MR; Sisk RA; Foster RE; Riemann CD; Miller DM
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):28-33. PubMed ID: 23418731
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification.
Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
Eur J Ophthalmol; 2014; 24(3):387-91. PubMed ID: 24170523
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes.
Khurana RN; Palmer JD; Porco TC; Wieland MR
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):56-61. PubMed ID: 25559510
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone intravitreal implant during phacoemulsification.
Agarwal A; Gupta V; Ram J; Gupta A
Ophthalmology; 2013 Jan; 120(1):211, 211.e1-5. PubMed ID: 23283186
[No Abstract] [Full Text] [Related]
15. Vitreous pillow for sustained-release intravitreous drug delivery implants.
Kapoor KG; Shultz RW; Iezzi R
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):181-2. PubMed ID: 23510043
[TBL] [Abstract][Full Text] [Related]
16. Surprises during intravitreal drug delivery-a report of three cases.
Venkatesh P; Chawla R; Shah B; Garg SP
Digit J Ophthalmol; 2017; 23(1):33-35. PubMed ID: 28924419
[TBL] [Abstract][Full Text] [Related]
17. Desegmentation of Ozurdex implant in vitreous cavity: report of two cases.
Agrawal R; Fernandez-Sanz G; Bala S; Addison PK
Br J Ophthalmol; 2014 Jul; 98(7):961-3. PubMed ID: 24648417
[TBL] [Abstract][Full Text] [Related]
18. Macular pseudohole development after sustained-release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusion.
Di Antonio L; Toto L; Carpineto P; Mastropasqua A; De Nicola C; Mastropasqua L
Eur J Ophthalmol; 2014; 24(1):134-7. PubMed ID: 23709332
[TBL] [Abstract][Full Text] [Related]
19. Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice.
Matonti F; Meyer F; Guigou S; Barthelemy T; Dumas S; Gobert F; Hajjar C; Merite PY; Parrat E; Rouhette H; Pommier S
Acta Ophthalmol; 2013 Nov; 91(7):e584-6. PubMed ID: 23764276
[No Abstract] [Full Text] [Related]
20. Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.
Sandali O; Akesbi J; Rodallec T; Laroche L; Nordmann JP
Can J Ophthalmol; 2013 Aug; 48(4):e78-80. PubMed ID: 23931489
[No Abstract] [Full Text] [Related]
[Next] [New Search]
